MoneyWeek’s comprehensive guide to the week’s share tips

The stocks and sharesthe British press is tipping and recommending you avoid this week.

Three to buy

Conviviality

Investors Chronicle

Shares in the company behind the off-licence chain Bargain Booze have big potential. After buying up several rivals, including wine distributor Bibendum, Conviviality could grow into a major alcohol wholesaler, supplying both the on- and off-trade sectors. The forecast dividend yield looks attractive at 4.3%. 196p

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

Halma

The Times

Halma, the Buckinghamshire-based technology firm that specialises in hazard detectors, from fire alarms to pregnancy scanners, has raised its dividend by at least 5% for 37 years. It is deal-hungry, spending more than £200m on acquisitions last year, swallowing a US digital firm. Organic growth on top was 6% last year. The shares are far from cheap on 25 times earnings, but deserve the premium. 933p

Pets at Home

Shares

"Snap up" shares in the pet accessory firm, says Shares. Pets at Home is now also the biggest small-animal veterinary firm in the UK, offering "resilient growth" in a fragmented market. It has raised its dividend pay-out policy and also plans to return excess cash as special dividends. 235p

Three to sell

Berkeley Group

The Daily Telegraph

Berkeley, the luxury London flat builder, has reported record results and has pledged to return £2m a year to investors in dividends over the next five years. But "cracks" are appearing. The property cycle looks like it has reached its peakand average prices in London are now falling. The forward price-earnings ratio is just eight, but that assumes a big jump in earnings. 2,954p

Circassia Pharmaceuticals

The Sunday Times

The allergy-treatment developer listed on the stock exchange at a price of 310p two years ago,in one of the market's biggest public floats.But progress at the company has been slow and too much of its value rides on results due from trials of its cat-allergy drug. Disappointment could herald a majorsell-off in the shares, if not the biotech sector more broadly. 270p

Servelec

Investors Chronicle

Dwindling NHS budgets have delayed orders at software specialist Servelec and its shares have "tanked". Orders anticipated for its technology division, which are linked to regulatory changes in the water sector, have also failed to materialise. The number of acquisitions made by management only adds to concerns. It's now time to bail out of the shares. 227p

And the rest

Directors' dealings

Shares in Derwent, which has more than six million square feet of high-end office space in central London, have bounced around this year along with other companies in the commercial property sector, as EU referendum polls have swung from side to side. Derwent's property portfolio in London is valued at £5bn, leaving it heavily exposed to the capital's commercial property market. Some analysts expect London property to suffer if the UK votes to leave the EU.

A German view

Beijing aims to increase the number of electric vehicles in China by 700,000 this year. Infineon's chips are also required for the photovoltaic cells that capture solar energy, and are central to the emergence of the "internet of things", whereby everyday objects such as cars and appliances are being automated and connected.